Edition:
United States

Cytos Biotechnology AG (CYTN.S)

CYTN.S on Swiss Exchange

--CHF
--
Change (% chg)

-- (--)
Prev Close
--
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,932
52-wk High
CHF51.00
52-wk Low
CHF18.50

CYTN.S

Chart for CYTN.S

About

Kuros Biosciences AG is a Switzerland-based biotechnology company engaged in the discovery, development and commercialization of biopharmaceutical products known as Immunodrugs. Immunodrugs are therapeutic vaccines intended for treating and preventing common chronic diseases, such as hypertension, nicotine addiction, allergic... (more)
No analyst recommendations are available for CYTN.S.

Overall

Beta: 1.29
Market Cap(Mil.): CHF112.11
Shares Outstanding(Mil.): 5.08
Dividend: --
Yield (%): --

Financials

  CYTN.S Industry Sector
P/E (TTM): 5.27 42.41 36.20
EPS (TTM): 4.18 -- --
ROI: -- -0.33 13.87
ROE: -- -3.14 14.78

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00
Provider : Edison Investment Research
$10.00
Provider : Directors Deals Ltd.
$12.00
Provider : Edison Investment Research
$10.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.